PRESS RELEASES AVECTAS Appoints Daniel Castro as Chief Business Officer January 11, 2021 Avectas Opens Canadian Development Site November 5, 2020 Avectas and UC Davis Collaborate on Cell Engineering Technology June 8, 2020 Avectas and ONK Therapeutics to develop off-the shelf cancer therapy May 6, 2020 Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies March 24, 2020 Avectas and CCRM Announce Collaboration to Accelerate Development of Novel Technology for Cell Therapies March 3, 2020 Avectas joins the new Competence Center for Next-Generation NK Cell-based Cancer Immunotherapy January 16, 2020 Avectas Raises $10 Million in Equity Finance April 9, 2019 Avectas named ‘Bio Science Lab of the Year’ at The Irish Laboratory Awards 2019 March 7, 2019 Avectas shortlisted in the ‘US- Ireland Research Innovation Awards’ March 7, 2019 Maynooth team secures €2.1m EU funding for cancer therapy March 20, 2018
Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies March 24, 2020
Avectas and CCRM Announce Collaboration to Accelerate Development of Novel Technology for Cell Therapies March 3, 2020
Avectas joins the new Competence Center for Next-Generation NK Cell-based Cancer Immunotherapy January 16, 2020